AG
MDGL icon

Artal Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Artal Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110,507
Closed -$29.5M – 126
2024
Q1 		$29.5M Buy
+110,507
New +$26M 0.75% 20
2019
Q3 		– Sell
-35,000
Closed -$3.67M – 111
2019
Q2 		$3.67M Hold
35,000
– – 0.15% 88
2019
Q1 		$4.38M Sell
35,000
-35,000
-50% -$4.35M 0.18% 81
2018
Q4 		$7.89M Buy
70,000
+20,000
+40% +$3.1M 0.29% 52
2018
Q3 		$10.7M Hold
50,000
– – 0.28% 52
2018
Q2 		$14M Buy
50,000
+5,000
+11% +$878K 0.3% 38
2018
Q1 		$5.26M Buy
+45,000
New +$5.55M 0.07% 66

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artal Group's MDGL Position: Q2 2024 in Review

Artal Group sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2024, closing a stake of 110,507 shares — an estimated $29.5M sold.

Artal Group first reported a position in MDGL in Q1 2018 and held it in 7 quarters. The position peaked at $29.5M in Q1 2024. 257 funds tracked by Wall St. Rank hold MDGL as of Q2 2024.

  • Artal Group reported no remaining Madrigal Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Artal Group sold 110,507 Madrigal Pharmaceuticals shares in Q2 2024, an estimated $29.5M.
  • Artal Group first reported a position in Madrigal Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Artal Group's Madrigal Pharmaceuticals position peaked at $29.5M in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2024.

Based on Artal Group's 13F filing for Q2 2024, filed 14 Aug 2024.